Novavax Inc (NVAX)

EBITDA

-$42.93M

Quarterly · Period ending: · USD

NVAX logo

NVAX EBITDA

Latest reported-$42.93M
NVAX Quarterly EBITDA (-$1.00M → -$42.93M)
High-resolution chart · PNG

NVAX ebitda history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novavax Inc EBITDA — Quarterly (USD)
Period endingEBITDA (USD)
-42,931,000
-543,000
28,852,000
-190,969,000
120,535,000
533,909,000
-53,479,000
-105,396,000
179,861,000
-129,030,000
-161,790,000
-117,293,000
71,056,000
-279,363,000
-172,686,000
-153,625,000
-496,113,000
217,711,000
-820,509,000
-306,946,000
-340,391,000
-212,902,000
-170,823,000
-191,664,000
-13,494,000
-21,892,000
-27,851,000
-13,760,000
-34,631,000
-38,232,000
-43,949,000
-39,126,000
-39,032,000
-40,870,000
-45,199,000
-37,558,000
-38,893,000
-38,230,000
-51,383,000
-60,522,000
-74,397,000
-72,868,000
-78,902,000
-31,504,000
-19,129,000
-23,025,000
-31,664,000
-18,641,000
-16,837,000
-13,393,000
-13,068,000
-14,561,000
-12,338,000
-9,508,000
-8,946,000
-6,849,000
-5,511,000
-7,030,000
-3,286,000
-3,968,000
-5,921,000
-7,062,000
-4,440,000
-9,998,000
-8,518,000
-11,158,000
-13,859,000
-7,965,000
-7,522,000
-6,843,000
-8,898,000
-9,720,000
-7,838,000
-7,011,000
-3,296,000
-8,907,000
-8,599,000
-7,839,000
-6,349,000
-5,390,000
-6,134,000
-4,019,000
7,146,000
-1,263,000
-4,189,000
-7,390,000
-9,019,000
-1,512,000
-6,632,000
-4,248,000
-2,748,000
-2,649,000
-4,349,000
-5,121,000
-4,611,000
-6,339,000
-5,234,000
-5,179,000
-2,137,000
-1,513,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.